Biotech

All Articles

Amgen documents very first period 3 gain for $400M chronic eczema medication

.Amgen has actually shared (PDF) the 1st period 3 records on its own $400 million chronic eczema med...

Biogen, UCB record stage 3 lupus win after neglecting earlier test

.Biogen and also UCB's gamble on advancing in to phase 3 astride an unsuccessful research study want...

Aptadir wishes brand new RNA preventions may reverse tricky cancers

.Italian biotech Aptadir Therapeutics has introduced along with the guarantee that its own pipe of p...

Wave surfs DMD success to regulatory authorities' doors, sending stockpile

.Surge Life Sciences has actually met its own goal in a Duchenne muscle dystrophy (DMD) research stu...

Sanofi plucks brand-new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is coming back to the pharma layer, occupy...

Achilles drops tissue therapy program, bandages for cutbacks after overlooking 'business feasibility' objectives

.Achilles Rehabs has actually shreded its own technique. The English biotech is actually stopping wo...

Aligos advertises stage 2 MASH win, reducing liver excess fat approximately 46%

.Aligos Rehabs is proclaiming a midstage gain in metabolic-dysfunction connected steatohepatitis (MA...

Basilea credit ratings $268M BARDA backing for antifungals, anti-biotics

.Basilea Pharmaceutica's job developing brand new antifungals has actually gotten a significant incr...

Capricor offers Europe civil liberties to late-stage DMD therapy for $35M

.Possessing currently scooped up the united state legal rights to Capricor Therapeutics' late-stage ...

FDA junks adcomm for Applied's rare health condition drug

.After dismissing the decision meeting for Applied Therapies' metabolic condition medication govores...